Perrigo Company�(NASDAQ:PRGO) decreased 1.43% to close at $67.03. PRGO traded 1.37 million shares for the day and its earning per share remained $2.64. Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and medical diagnostic products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products.
United Therapeutics Corporation�(NASDAQ:UTHR) decreased 1.07% to close at $63.55. UTHR traded 1.31 million shares for the day and its earning per share remained $1.57. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and Internationally. It offers Remodulin, Tyvaso, and Adcirca (tadalafil) tablets for the treatment of pulmonary arterial hypertension (PAH); and CardioPAL SAVI and decipher cardiac monitors, and CardioPAL SAVI wireless cardiac event monitors for cardiac arrhythmias and ischemic heart disease.
Immucor, Inc.�(NASDAQ:BLUD) decreased 1.22% to close at $20.28. BLUD traded 1.29 million shares for the day and its earning per share remained $1.17. Immucor, Inc., an in vitro diagnostics company, engages in the development, manufacture, and sale of reagents and automated systems. Its products are used by hospitals, reference laboratories, and donor centers to detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. The company?s reagent products are used in tests to identify blood group and type; to detect and identify red cell antibodies or red cell antigens; to detect and identify platelet antibodies; and to determine blood compatibility.
No comments:
Post a Comment